Fotografia 1: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 2: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 3: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 4: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 5: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 6: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 7: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 8: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 9: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 10: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 11: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 12: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 13: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 14: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 15: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 16: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 17: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 18: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 19: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 20: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 21: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 22: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 23: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 24: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 25: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 26: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 27: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 28: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 29: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 30: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 31: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 32: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 33: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 34: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 35: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 36: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 37: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 38: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 39: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 40: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 41: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 42: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 43: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 44: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 45: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 46: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 47: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 48: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
Fotografia 49: EP Plenary session - Meeting the Global Covid 19 challenge: effects of waiver of the WTO TRIPS agreement on Covid-19 vaccines, treatment, equipment and manufacturing capacity in developing countries
/2 páginas